|Bid||0.00 x 900|
|Ask||349.20 x 1000|
|Day's Range||332.37 - 354.39|
|52 Week Range||150.41 - 456.23|
|Beta (5Y Monthly)||0.79|
|PE Ratio (TTM)||138.61|
|Earnings Date||Oct 27, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||462.94|
During the popular "Lightning Round" segment of Mad Money Wednesday night, one caller asked Jim Cramer his opinion of the diabetes monitor maker DexCom : "Let's start a position in DexCom if you don't already have one," was Cramer's advice. In this daily bar chart of DXCM, below, we can see that prices have declined enough to test the rising 200-day moving average line. The On-Balance-Volume (OBV) line has gone nowhere since May and downward since August.
DexCom, Inc. (NASDAQ:DXCM) just released its quarterly report and things are looking bullish. It was overall a...
DexCom's (DXCM) third-quarter results benefit from solid segmental performance.